PFE

Pfizer
D

PFE

Arincen59/100B
29.390
USD
-0.49
(-1.64%)
Post Trading·29.320USD-0.070(-0.24%)
Last updated: · Delayed 15 min
Fair valueNot reliable
Q4 FY2026 · Earnings report
EPS estimate 0.72Revenue estimate 17.14B
OverviewFinancialsSignalsNewsForecastEarningsDividendsCompany

Pfizer earnings

Pfizer reports its Q4 FY2026 results on 2 February 2027, before the market opens. Analysts expect earnings per share of 0.72 USD and revenue of 17.14B USD.

In Q3 FY2026, reported on 3 November 2026, Pfizer earned 0.87 USD a share against the 0.74 USD analysts expected (+18.4%), on revenue of 16.58B USD against 15.85B USD (+4.6%).

Last EPS surprise
+18.4%
Last revenue surprise
+4.6%
Move after the last report
-2.3%
Average move after earnings
2.2%

EPS and revenue against estimates

Next earnings · Q4 FY2026
EPS estimate
0.72 USD
Revenue estimate
17.14B USD
Last quarter · Q3 FY2026
EPS0.87Beat +18.4%Revenue16.58BBeat +4.6%

Revenue

ReportedEstimate

EPS

ReportedEstimate
PeriodReport dateEPS estimateReported EPSSurpriseEPS growthRevenue estimateReported revenueSurpriseRevenue growthNext-day move
Q3 FY20270.75——-14.02%15.45B——-6.82%—
Q2 FY20270.66——-14.77%14.49B——-3.62%—
Q1 FY20270.69——-8.33%14.09B——-2.51%—
Q4 FY20260.72——+9.09%17.14B——-2.37%—
Q3 FY20260.740.87+18.37%0.00%15.85B16.58B+4.61%-0.43%-2.3%
Q2 FY20260.680.77+12.90%-1.28%14.40B15.03B+4.41%+2.60%+1.4%
Q1 FY20260.720.75+3.88%-18.48%13.84B14.45B+4.41%+5.37%+0.5%
Q4 FY20250.570.66+16.40%+4.76%16.85B17.56B+4.20%-1.16%-3.4%
Q3 FY20250.630.87+37.44%-17.92%16.50B16.65B+0.94%-5.92%-1.5%
Q2 FY20250.580.78+34.48%+30.00%13.56B14.65B+8.06%+10.31%+5.1%
Q1 FY20250.670.92+38.14%+12.20%13.92B13.72B-1.47%-7.82%+3.3%
Q4 FY20240.470.63+33.59%+530.00%17.35B17.76B+2.38%+24.66%-1.3%
Q3 FY20240.611.06+72.64%—14.92B17.70B+18.63%+33.78%-1.4%
Q2 FY20240.460.60+31.00%-10.45%12.96B13.28B+2.48%+4.31%+2.1%
Q1 FY20240.520.82+58.91%-33.33%13.87B14.88B+7.25%-18.61%+6.1%
Q4 FY2023-0.190.10+152.63%-91.23%14.25B14.25B+0.00%-41.34%-1.6%
Q3 FY2023-0.32-0.17+46.88%-109.55%12.72B13.23B+4.00%-41.55%+0.0%
Q2 FY20230.560.67+19.64%-67.16%12.08B12.73B+5.38%-54.10%-1.2%
Q1 FY20230.981.23+25.51%-26.35%16.59B18.28B+10.18%-28.76%-0.3%
Q4 FY20221.051.14+8.57%+5.56%24.38B24.29B-0.38%+1.90%+1.4%
Q3 FY20221.391.78+28.06%+32.84%21.07B22.64B+7.43%-6.04%+3.0%
Q2 FY20221.782.04+14.61%+90.65%25.49B27.74B+8.85%+46.79%-2.4%
Q1 FY20221.471.67+13.61%+79.57%24.10B25.66B+6.48%+75.98%+1.8%
Q4 FY20210.851.08+27.06%+157.14%24.16B23.84B-1.32%+104.02%-2.9%
Q3 FY20211.091.34+22.94%+86.11%22.38B24.09B+7.65%+98.62%+4.2%
Q2 FY20210.971.07+10.31%+37.18%22.87B18.90B-17.38%+60.15%+3.3%
Q1 FY20210.770.93+20.78%+16.25%13.55B14.58B+7.61%+21.23%+0.4%
Q4 FY20200.460.42-8.70%-23.64%6.69B11.68B+74.64%-7.91%-2.2%
Q3 FY20200.700.72+2.86%-4.00%11.96B12.13B+1.41%-4.33%-1.4%
Q2 FY20200.660.78+18.18%-2.50%9.99B11.80B+18.18%-11.03%+3.8%
Q1 FY20200.710.80+12.68%-5.88%10.98B12.03B+9.59%-8.31%-0.9%
Q4 FY20190.570.55-3.51%-14.06%13.15B12.69B-3.51%-9.22%-5.1%
Q3 FY20190.630.75+19.05%-3.85%10.48B12.68B+20.97%-4.65%+2.5%
Q2 FY20190.750.80+6.67%-1.23%12.44B13.26B+6.67%-1.50%-3.8%
Q1 FY20190.750.85+13.33%+10.39%11.57B13.12B+13.33%+1.64%+2.5%
Q4 FY20180.630.64+1.59%+3.23%13.76B13.98B+1.58%+1.99%+3.1%
Q3 FY20180.750.78+4.00%+16.42%12.79B13.30B+4.00%+0.99%-0.7%
Q2 FY20180.740.81+9.46%+20.90%12.30B13.47B+9.46%+4.42%+3.4%
Q1 FY20180.740.77+4.05%+11.59%12.57B12.91B+2.67%+0.99%-3.4%
Q4 FY20170.560.62+10.71%+31.91%12.38B13.70B+10.71%+0.56%-3.1%
Q3 FY20170.650.67+3.08%+9.84%12.77B13.17B+3.08%+0.94%-0.2%
Q2 FY20170.660.67+1.52%+4.69%12.70B12.90B+1.52%-1.91%-0.1%
Q1 FY20170.670.69+2.99%+2.99%12.41B12.78B+2.99%-1.74%-0.5%
Q4 FY20160.500.47-6.00%-11.32%14.50B13.63B-6.01%-2.99%+1.4%
Q3 FY20160.620.61-1.61%+1.67%13.26B13.05B-1.61%+7.93%-2.0%
Q2 FY20160.620.64+3.23%+14.29%12.74B13.15B+3.23%+10.92%-2.5%
Q1 FY20160.550.67+21.82%+31.37%10.68B13.01B+21.82%+19.71%+2.8%
Q4 FY20150.520.53+1.92%-1.85%13.78B14.05B+1.92%+7.08%-0.1%
Q3 FY20150.510.60+17.65%+5.26%10.27B12.09B+17.65%-2.22%+2.4%
Q2 FY20150.510.56+9.80%-3.45%11.01B11.85B+7.69%-7.20%+2.9%
Q1 FY20150.500.51+2.00%-10.53%10.44B10.86B+4.08%-4.31%-0.3%
Q4 FY20140.530.54+1.89%-3.57%12.88B13.12B+1.89%-3.25%-0.6%
Q3 FY20140.560.57+1.79%-1.72%11.93B12.36B+3.64%-2.23%+0.2%
Q2 FY20140.570.58+1.75%+3.57%12.55B12.77B+1.75%-1.54%-1.2%
Q1 FY20140.550.57+3.64%+5.56%10.95B11.35B+3.64%-15.90%-2.6%
Q4 FY20130.530.56+5.66%+19.15%12.59B13.56B+7.69%-10.02%+2.6%
Q3 FY20130.560.58+3.57%+9.43%12.21B12.64B+3.57%-9.54%+1.7%
Q2 FY20130.540.56+3.70%-9.68%12.74B12.97B+1.82%-13.84%+0.5%
Q1 FY20130.550.54-1.82%-6.90%12.64B13.50B+6.81%-12.37%-4.5%
Q4 FY20120.440.47+6.82%-6.00%13.00B15.07B+15.87%-10.02%+3.2%
Q3 FY20120.530.530.00%-14.52%12.95B13.98B+7.90%-18.71%-1.3%
Q2 FY20120.540.62+14.81%+3.33%12.17B15.06B+23.77%-11.35%+1.4%
Q1 FY20120.560.58+3.57%-3.33%13.37B15.41B+15.24%-6.65%-0.5%
Q4 FY20110.470.50+6.38%+6.38%15.17B16.75B+10.37%-4.64%-0.8%
Q3 FY20110.560.62+10.71%+14.81%15.00B17.19B+14.61%+6.32%+0.3%
Q2 FY20110.590.60+1.69%-3.23%16.21B16.98B+4.77%-1.98%-4.5%
Q1 FY20110.590.60+1.69%0.00%15.76B16.50B+4.73%-1.48%-2.8%
Q4 FY20100.460.47+2.17%-4.08%15.13B17.56B+16.04%+6.19%+5.5%
Q3 FY20100.510.54+5.88%+5.88%15.11B16.17B+7.05%+39.15%-1.0%
Q2 FY20100.520.62+19.23%+29.17%14.37B17.33B+20.59%+57.75%+5.6%
Q1 FY20100.530.60+13.21%+11.11%14.64B16.75B+14.40%+54.14%+2.0%
Q4 FY20090.500.49-2.00%-24.62%16.87B16.54B-2.00%+33.95%-3.2%
Q3 FY20090.480.51+6.25%-17.74%10.94B11.62B+6.25%-2.94%-0.2%
Q2 FY20090.470.48+2.13%-12.73%10.76B10.98B+2.13%-9.44%+1.1%
Q1 FY20090.490.54+10.20%-11.48%9.86B10.87B+10.20%-8.28%-0.7%
Q4 FY20080.590.65+10.17%+25.00%11.21B12.35B+10.17%-4.07%-10.3%
Q3 FY20080.600.62+3.33%+6.90%11.59B11.97B+3.33%-0.14%0.0%
Q2 FY20080.540.55+1.85%+30.95%11.91B12.13B+1.85%+9.43%+4.0%
Q1 FY20080.660.61-7.58%-10.29%12.82B11.85B-7.58%-5.02%-3.3%
Q4 FY20070.470.52+10.64%+20.93%11.63B12.87B+10.64%+2.12%+2.8%
Q3 FY20070.530.58+9.43%+7.41%10.96B11.99B+9.43%-2.36%-0.0%
Q2 FY20070.500.42-16.00%-16.00%13.20B11.08B-16.00%-5.60%-3.2%
Q1 FY20070.570.68+19.30%+11.48%10.46B12.47B+19.30%-1.47%-0.4%
Q4 FY20060.420.43+2.38%-15.69%12.30B12.60B+2.44%-7.28%-1.0%
Q3 FY20060.450.54+20.00%+5.88%10.23B12.28B+20.00%+0.75%-1.5%
Q2 FY20060.480.50+4.17%+8.70%11.27B11.74B+4.17%-5.51%+1.8%
Q1 FY20060.530.61+15.09%+12.96%10.21B12.66B+24.04%-3.29%-0.4%
Q4 FY20050.420.51+21.43%-12.07%10.68B13.59B+27.27%-8.91%+4.0%
Q3 FY20050.480.51+6.25%-7.27%10.60B12.19B+14.99%-5.00%-8.6%
Q2 FY20050.440.46+4.55%-2.13%10.95B12.43B+13.43%+1.23%-1.1%
Q1 FY20050.530.54+1.89%+3.85%11.92B13.09B+9.84%+4.84%-0.7%
Q4 FY20040.590.58-1.69%+9.43%15.18B14.92B-1.70%+5.34%-1.7%
Q3 FY20040.540.55+1.85%+17.02%12.60B12.83B+1.85%+2.62%-2.4%
Q2 FY20040.470.470.00%+56.67%12.27B12.27B0.00%+22.83%-1.1%
Q1 FY20040.510.52+1.96%+15.56%12.25B12.49B+1.96%+46.48%-2.3%
Q4 FY20030.510.53+3.92%+10.42%13.61B14.17B+4.08%+96.86%+1.4%
Q3 FY20030.440.47+6.82%+20.51%11.56B12.50B+8.17%+43.31%-2.8%
Q2 FY20030.290.30+3.45%-9.09%9.57B9.99B+4.42%+24.40%+1.5%
Q1 FY20030.440.45+2.27%+15.38%8.32B8.53B+2.50%+1.27%+0.7%
Q4 FY20020.470.48+2.13%+41.18%7.04B7.20B+2.17%-20.31%+0.7%
Q3 FY20020.390.390.00%+14.71%8.00B8.73B+9.12%+10.47%+0.3%
Q2 FY20020.320.33+3.13%+10.00%7.07B8.03B+13.54%+4.51%-10.6%
Q1 FY20020.390.390.00%+18.18%7.75B8.42B+8.66%+10.11%-5.1%
Q4 FY20010.340.340.00%+25.93%9.03B9.03B0.00%+11.40%+2.4%
Q3 FY20010.330.34+3.03%+25.93%7.59B7.90B+4.00%+9.62%+1.3%
Q2 FY20010.290.30+3.45%+30.43%7.37B7.69B+4.32%+9.16%+1.8%
Q1 FY20010.310.33+6.45%+17.86%7.12B7.65B+7.31%+77.17%-3.6%
Q4 FY20000.270.270.00%+8.00%8.11B8.11B0.00%+79.85%+0.2%
Q3 FY20000.260.27+3.85%+17.39%6.89B7.21B+4.53%+80.49%-5.2%
Q2 FY20000.220.23+4.55%+21.05%6.69B7.04B+5.32%+86.32%+4.2%
Q1 FY20000.250.28+12.00%+33.33%6.39B4.32B-32.51%+9.88%+4.1%
Q4 FY19990.230.25+8.70%+38.89%4.12B4.51B+9.52%+16.58%-1.7%
Q3 FY19990.210.23+9.52%+35.29%6.16B3.99B-35.19%+19.88%+6.3%
Q2 FY19990.170.19+11.76%+11.76%—3.78B—+4.02%-1.8%
Q1 FY19990.210.210.00%+16.67%—3.93B—+17.61%-10.1%
Q4 FY19980.170.18+5.88%+28.57%3.64B3.87B+6.25%+10.58%-0.1%
Q3 FY19980.190.17-10.53%+13.33%6.49B3.33B-48.67%+7.63%-5.9%
Q2 FY19980.150.17+13.33%+41.67%5.11B3.63B-28.97%+24.72%+2.2%
Q1 FY19980.180.180.00%+12.50%5.22B3.34B-36.00%+11.23%-2.0%
Q4 FY19970.140.140.00%+7.69%3.50B3.50B0.00%+10.63%+5.0%
Q3 FY19970.150.150.00%+15.38%4.76B3.09B-35.00%+10.38%+4.6%
Q2 FY19970.120.120.00%+20.00%4.14B2.91B-29.69%+9.47%+1.5%
Q1 FY19970.160.160.00%+14.29%4.78B3.00B-37.18%+11.93%-0.6%
Q4 FY19960.130.130.00%+18.18%3.16B3.16B0.00%+15.15%+0.4%
Q3 FY19960.130.130.00%+18.18%—2.80B—+10.42%+1.6%
Q2 FY19960.100.100.00%+25.00%—2.66B—+7.21%-1.8%
Q1 FY19960.130.14+7.69%+27.27%—2.68B—+11.62%-0.5%
Q4 FY19950.110.110.00%+22.22%—2.74B—+19.31%-0.2%
Q3 FY19950.110.110.00%+22.22%—2.54B—+22.34%+2.1%
Q2 FY19950.080.080.00%+14.29%—2.48B—+29.05%+0.3%
Q1 FY19950.110.110.00%+10.00%—2.40B—+21.18%-1.0%
Q4 FY19940.090.090.00%+12.50%—2.30B—+15.63%+2.6%
Q3 FY19940.090.090.00%+12.50%—2.07B—+10.81%+0.2%
Q2 FY19940.070.070.00%+16.67%—1.92B—+9.98%-3.3%
Q1 FY19940.100.100.00%+25.00%—1.98B—+6.19%+3.6%
Q4 FY19930.080.080.00%+2,246.04%—1.99B—+2.16%-7.3%
Q3 FY19930.080.080.00%——1.87B——-1.2%
Q2 FY19930.060.060.00%+20.00%—1.75B—+3.22%-0.6%
Q1 FY19930.080.080.00%——1.87B——+5.1%
Q4 FY19920.070.070.00%+30,334.78%—1.83B—-1.22%+4.3%
Q4 FY1992—0.00—+1,382.61%—1.95B—+5.24%-0.9%
Q2 FY1992—0.05—0.00%—1.69B—+3.87%-1.7%
Q4 FY1991—0.07—+83.34%—1.76B—-1.34%+2.2%
Q4 FY1991—0.00—-99.40%—1.85B—+3.64%-1.9%
Q3 FY1991—0.07—+16.67%—1.77B—+7.91%+0.8%
Q2 FY1991—0.05—+25.00%—1.63B—+9.05%+1.4%
Q4 FY1990—0.07—+75.00%—1.70B—-70.10%+1.0%
Q4 FY1990—0.04—-4.55%—1.79B—-68.52%+0.3%
Q3 FY1990—0.06—0.00%—1.64B—+14.22%+3.9%
Q2 FY1990—0.04—+33.33%—1.50B—+14.82%+0.8%
Q4 FY1989—0.06—+26.32%—1.48B—-72.48%-2.5%
Q4 FY1989—0.04—-15.79%—5.67B—+5.31%+1.8%
Q3 FY1989—0.06—0.00%—1.44B—+4.02%-1.1%
Q2 FY1989—0.03—-40.00%—1.30B—-2.52%0.0%
Q4 FY1988—0.06—+41.18%—1.44B—-70.81%+0.9%
Q4 FY1988—0.05—+11.76%—5.39B—+9.46%-0.4%
Q3 FY1988—0.06—+20.00%—1.38B—+6.55%-0.5%
Q2 FY1988—0.05—+25.00%—1.34B—+8.91%+2.0%
Q4 FY1987—0.06—+50.00%—1.30B—-71.00%-0.9%
Q4 FY1987—0.04—+6.25%—4.92B—+9.92%-2.7%
Q3 FY1987—0.05—+25.00%—1.30B—+11.59%-0.4%
Q2 FY1987—0.04—0.00%—1.23B—+9.77%-1.7%
Q4 FY1986—0.05—+42.86%—1.12B—-72.18%+1.1%
Q4 FY1986—0.04—+14.29%—4.48B—+11.22%-0.4%
Q3 FY1986—0.04—0.00%—1.16B—+14.84%+1.3%
Q2 FY1986—0.04———1.12B——+0.4%
Q4 FY1985—0.04———1.03B——-1.3%
Q4 FY1985—0.04———4.02B——+0.5%
Q3 FY1985—0.04———1.01B——+1.1%

The move is the shares' change on the trading day after the report: after a report after the close, the next day's close on the report day's; before the open, the report day's close on the day before's. Surprise is the reported figure against the analysts' average estimate.

Q4 FY2026

What the market is waiting for

From the last earnings call, the company's guidance and analysts' previews, and checked against the report when it comes.

High importanceWaiting for 2 Feb

Revenue outlook

Expected2027 revenue guidance of about $59.99 billionanalysts' consensus
The resultComes with the report on 2 Feb

The outlook will show how much Pfizer expects sales to be affected by competition for its older medicines.

Beat record

On average, analysts' EPS estimate was 42.5% off the result, either way, and their revenue estimate 4.9%, over the last 12 quarters.

EPS beats
98 / 136
Revenue beats
94 / 118
Average EPS surprise, last 12
+42.5%
Since
January 1993

See also:Forecast,EPS,Income statement

Common questions about Pfizer's earnings

Source: Financial Modeling Prep

Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.